Filtered By:
Procedure: Heart Valve Surgery

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 3059 results found since Jan 2013.

Intra-Arterial Thrombectomy for Acute Ischemic Stroke Related to the Procoagulant Effect of Warfarin in A Patient with Atrial Fibrillation and Bioprosthetic Valve Replacement
CONCLUSION: This report describes the roles of endovascular therapy and NOAC in patients with similar highly complex conditions and has clinical relevance for therapeutic plans in the clinical setting.PMID:37674421
Source: Acta Neurologica Taiwanica - September 7, 2023 Category: Neurology Authors: Hsu-Tung Huang Yi-Ting Huang David Yen-Ting Chen Lung Chan Chien-Tai Hong Chen-Chih Chung Source Type: research

Addressing the longitudinal components of surgical treatments
AbstractDespite their pre- and postoperative components, surgical treatment strategies have typically been cast as point interventions in causal inference research. When longitudinal perioperative components affect outcomes of interest, leaving them unspecified or failing to measure adherence to them complicates the interpretation of effect estimates. Inspired by two recent landmark trials that assessed the risk of stroke or death after transcatheter aortic valve replacement (TAVR) compared with surgical aortic valve replacement (SAVR), the PARTNER 3 trial and the Evolut Low Risk trial, we discuss possible ways that differ...
Source: European Journal of Epidemiology - September 4, 2023 Category: Epidemiology Source Type: research

Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial
EuroIntervention. 2023 Sep 1:EIJ-D-23-00232. doi: 10.4244/EIJ-D-23-00232. Online ahead of print.ABSTRACTTranscatheter aortic valve implantation (TAVI) has become the preferred treatment option for patients with severe aortic stenosis at increased risk for surgical aortic valve replacement (SAVR) and for older patients irrespective of risk. However, in younger, low-risk patients for whom both therapeutic options, TAVI and SAVR, are applicable, the optimal treatment strategy remains controversial, as data on long-term outcomes remain limited. The DEDICATE-DZHK6 Trial is an investigator-initiated, industry-independent, prospe...
Source: EuroIntervention - September 1, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Moritz Seiffert Reinhard Vonthein Helmut Baumgartner Michael A Borger Yeong-Hoon Choi Volkmar Falk Norbert Frey Andreas Hagendorff Christian Hagl Christian Hamm Inke R K önig Ulf Landmesser Steffen Massberg Hermann Reichenspurner Holger Thiele Raphael Tw Source Type: research

Early Aortic Valve Replacement in Symptomatic Normal-Flow, Low-Gradient Severe Aortic Stenosis: A Propensity Score-Matched Retrospective Cohort Study
CONCLUSIONS: An early AVR strategy may be beneficial in reducing the risk of a composite outcome of death or hospitalization for HF in symptomatic patients with NFLG severe AS. Future randomized studies are required to validate and confirm our findings.PMID:37653715 | DOI:10.4070/kcj.2023.0022
Source: Korean Circulation Journal - September 1, 2023 Category: Cardiology Authors: Kyu Kim Iksung Cho Kyu-Yong Ko Seung-Hyun Lee Sak Lee Geu-Ru Hong Jong-Won Ha Chi Young Shim Source Type: research

Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial
EuroIntervention. 2023 Sep 1:EIJ-D-23-00232. doi: 10.4244/EIJ-D-23-00232. Online ahead of print.ABSTRACTTranscatheter aortic valve implantation (TAVI) has become the preferred treatment option for patients with severe aortic stenosis at increased risk for surgical aortic valve replacement (SAVR) and for older patients irrespective of risk. However, in younger, low-risk patients for whom both therapeutic options, TAVI and SAVR, are applicable, the optimal treatment strategy remains controversial, as data on long-term outcomes remain limited. The DEDICATE-DZHK6 Trial is an investigator-initiated, industry-independent, prospe...
Source: EuroIntervention - September 1, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Moritz Seiffert Reinhard Vonthein Helmut Baumgartner Michael A Borger Yeong-Hoon Choi Volkmar Falk Norbert Frey Andreas Hagendorff Christian Hagl Christian Hamm Inke R K önig Ulf Landmesser Steffen Massberg Hermann Reichenspurner Holger Thiele Raphael Tw Source Type: research

Early Aortic Valve Replacement in Symptomatic Normal-Flow, Low-Gradient Severe Aortic Stenosis: A Propensity Score-Matched Retrospective Cohort Study
CONCLUSIONS: An early AVR strategy may be beneficial in reducing the risk of a composite outcome of death or hospitalization for HF in symptomatic patients with NFLG severe AS. Future randomized studies are required to validate and confirm our findings.PMID:37653715 | DOI:10.4070/kcj.2023.0022
Source: Korean Circulation Journal - September 1, 2023 Category: Cardiology Authors: Kyu Kim Iksung Cho Kyu-Yong Ko Seung-Hyun Lee Sak Lee Geu-Ru Hong Jong-Won Ha Chi Young Shim Source Type: research

Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial
EuroIntervention. 2023 Sep 1:EIJ-D-23-00232. doi: 10.4244/EIJ-D-23-00232. Online ahead of print.ABSTRACTTranscatheter aortic valve implantation (TAVI) has become the preferred treatment option for patients with severe aortic stenosis at increased risk for surgical aortic valve replacement (SAVR) and for older patients irrespective of risk. However, in younger, low-risk patients for whom both therapeutic options, TAVI and SAVR, are applicable, the optimal treatment strategy remains controversial, as data on long-term outcomes remain limited. The DEDICATE-DZHK6 Trial is an investigator-initiated, industry-independent, prospe...
Source: EuroIntervention - September 1, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Moritz Seiffert Reinhard Vonthein Helmut Baumgartner Michael A Borger Yeong-Hoon Choi Volkmar Falk Norbert Frey Andreas Hagendorff Christian Hagl Christian Hamm Inke R K önig Ulf Landmesser Steffen Massberg Hermann Reichenspurner Holger Thiele Raphael Tw Source Type: research

Glutamate infusion reduces myocardial dysfunction after coronary artery bypass grafting according to NT-proBNP: summary of two randomized controlled trials (GLUTAMICS I-II)
CONCLUSIONS: Infusion of glutamate reduced postoperative rise in NT-proBNP after CABG in medium to high-risk patients. A significantly blunted effect was observed only in insulin-treated diabetes patients.CLINICAL TRIAL REGISTRATION: NCT02592824, https://clinicaltrials.gov/ct2/show/NCT02592824.PMID:37657522 | DOI:10.1016/j.ajcnut.2023.08.012
Source: The American Journal of Clinical Nutrition - September 1, 2023 Category: Nutrition Authors: Jonas Holm Farkas Vanky Rolf Svedjeholm Source Type: research

Early Aortic Valve Replacement in Symptomatic Normal-Flow, Low-Gradient Severe Aortic Stenosis: A Propensity Score-Matched Retrospective Cohort Study
CONCLUSIONS: An early AVR strategy may be beneficial in reducing the risk of a composite outcome of death or hospitalization for HF in symptomatic patients with NFLG severe AS. Future randomized studies are required to validate and confirm our findings.PMID:37653715 | DOI:10.4070/kcj.2023.0022
Source: Korean Circulation Journal - September 1, 2023 Category: Cardiology Authors: Kyu Kim Iksung Cho Kyu-Yong Ko Seung-Hyun Lee Sak Lee Geu-Ru Hong Jong-Won Ha Chi Young Shim Source Type: research

Glutamate infusion reduces myocardial dysfunction after coronary artery bypass grafting according to NT-proBNP: summary of two randomized controlled trials (GLUTAMICS I-II)
CONCLUSIONS: Infusion of glutamate reduced postoperative rise in NT-proBNP after CABG in medium to high-risk patients. A significantly blunted effect was observed only in insulin-treated diabetes patients.CLINICAL TRIAL REGISTRATION: NCT02592824, https://clinicaltrials.gov/ct2/show/NCT02592824.PMID:37657522 | DOI:10.1016/j.ajcnut.2023.08.012
Source: Am J Clin Nutr - September 1, 2023 Category: Nutrition Authors: Jonas Holm Farkas Vanky Rolf Svedjeholm Source Type: research

Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial
EuroIntervention. 2023 Sep 1:EIJ-D-23-00232. doi: 10.4244/EIJ-D-23-00232. Online ahead of print.ABSTRACTTranscatheter aortic valve implantation (TAVI) has become the preferred treatment option for patients with severe aortic stenosis at increased risk for surgical aortic valve replacement (SAVR) and for older patients irrespective of risk. However, in younger, low-risk patients for whom both therapeutic options, TAVI and SAVR, are applicable, the optimal treatment strategy remains controversial, as data on long-term outcomes remain limited. The DEDICATE-DZHK6 Trial is an investigator-initiated, industry-independent, prospe...
Source: EuroIntervention - September 1, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Moritz Seiffert Reinhard Vonthein Helmut Baumgartner Michael A Borger Yeong-Hoon Choi Volkmar Falk Norbert Frey Andreas Hagendorff Christian Hagl Christian Hamm Inke R K önig Ulf Landmesser Steffen Massberg Hermann Reichenspurner Holger Thiele Raphael Tw Source Type: research

Early Aortic Valve Replacement in Symptomatic Normal-Flow, Low-Gradient Severe Aortic Stenosis: A Propensity Score-Matched Retrospective Cohort Study
CONCLUSIONS: An early AVR strategy may be beneficial in reducing the risk of a composite outcome of death or hospitalization for HF in symptomatic patients with NFLG severe AS. Future randomized studies are required to validate and confirm our findings.PMID:37653715 | DOI:10.4070/kcj.2023.0022
Source: Korean Circulation Journal - September 1, 2023 Category: Cardiology Authors: Kyu Kim Iksung Cho Kyu-Yong Ko Seung-Hyun Lee Sak Lee Geu-Ru Hong Jong-Won Ha Chi Young Shim Source Type: research